Skip to Content

Media

FAQS

Do you want to know something about Almirall?
These are the questions people most often ask of us.

faqs
MEDIA CONTACTS

Cohn & Wolfe
Tel: +34 91 531 50 97
Contact: Adriana Ibargüen

Almirall Media Relations
Tel: +34 93 291 30 00
Contact: Corporate Communications

Contact us

Request further information about Almirall

Contact us

News

21-12-2016

Almirall and Mercachem announce a collaboration for the development of cytokine blockers

Almirall S.A. and Mercachem announced today that they have entered into an exclusive discovery collaboration focusing ...

12-12-2016

Almirall and Nuevolution enter into a Strategic Collaboration to Develop RORγt inhibitors for treatment of Dermatology diseases and Psoriatic Arthritis

Almirall S.A. and Nuevolution A/S (a wholly owned subsidiary of Nuevolution AB (publ)) announced today that they have ...

07-11-2016

Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in US

Barcelona, 7 th November, 2016 .- Almirall, the global pharmaceutical company based in Barcelona, has announced its 9M ...

28-10-2016

Almirall presents the derma story ‘Not Today' to raise awareness about the social impact of psoriasis

World Psoriasis Day (29 th October)   Psoriasis affects more than 125M worldwide 1 . It can interfere with dail ...